ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Research Program Announcement

February 13, 1981

NCI Cooperative Group, Cancer Center Trials Listed

June 29, 2007

NCI FY94 Budget To Fund 860 Grants, Increase Prevention, Construction Money

December 3, 1993

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983